These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1255 related articles for article (PubMed ID: 23302119)

  • 81. [Correlation of free fetal DNA with beta-human chorionin gonadotropin in circulation in pregnant women with high risk of Down's syndrome].
    Meng JL; Wang XT; Chen ZJ
    Zhonghua Fu Chan Ke Za Zhi; 2009 Sep; 44(9):661-4. PubMed ID: 20079176
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Cell-free DNA analysis for noninvasive examination of trisomy.
    Norton ME; Jacobsson B; Swamy GK; Laurent LC; Ranzini AC; Brar H; Tomlinson MW; Pereira L; Spitz JL; Hollemon D; Cuckle H; Musci TJ; Wapner RJ
    N Engl J Med; 2015 Apr; 372(17):1589-97. PubMed ID: 25830321
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Implementation of maternal blood cell-free DNA testing in early screening for aneuploidies.
    Gil MM; Quezada MS; Bregant B; Ferraro M; Nicolaides KH
    Ultrasound Obstet Gynecol; 2013 Jul; 42(1):34-40. PubMed ID: 23744609
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Second trimester maternal serum screening using alpha fetoprotein, free beta human chorionic gonadotropin and maternal age specific risk: result of chromosomal abnormalities detected in screen positive for Down syndrome in an Asian population.
    Chao AS; Chung CL; Wu CD; Chang SD; Cheng PJ; Lin YT; Soong YK
    Acta Obstet Gynecol Scand; 1999 May; 78(5):393-7. PubMed ID: 10326883
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Discordant circulating fetal DNA and subsequent cytogenetics reveal false negative, placental mosaic, and fetal mosaic cfDNA genotypes.
    Lebo RV; Novak RW; Wolfe K; Michelson M; Robinson H; Mancuso MS
    J Transl Med; 2015 Aug; 13():260. PubMed ID: 26260800
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Efficiency of non-invasive prenatal screening in pregnant women at advanced maternal age.
    Zhu H; Jin X; Xu Y; Zhang W; Liu X; Jin J; Qian Y; Dong M
    BMC Pregnancy Childbirth; 2021 Jan; 21(1):86. PubMed ID: 33499806
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [CLINICAL IMPLEMENTATION OF CELL-FREE DNA ANALYSIS IN MATERNAL BLOOD IN SCREENING FOR ANEUPLOIDIES IN SINGLETON PREGNANCIES].
    Chaveeva P; Yankova M; Stratieva V; Dimitrov I; Shterev A
    Akush Ginekol (Sofiia); 2016; 55(2):10-5. PubMed ID: 27509651
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Noninvasive prenatal testing of trisomies 21 and 18 by massively parallel sequencing of maternal plasma DNA in twin pregnancies.
    Huang X; Zheng J; Chen M; Zhao Y; Zhang C; Liu L; Xie W; Shi S; Wei Y; Lei D; Xu C; Wu Q; Guo X; Shi X; Zhou Y; Liu Q; Gao Y; Jiang F; Zhang H; Su F; Ge H; Li X; Pan X; Chen S; Chen F; Fang Q; Jiang H; Lau TK; Wang W
    Prenat Diagn; 2014 Apr; 34(4):335-40. PubMed ID: 24357023
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The impact of first trimester screening and early fetal anomaly scan on invasive testing rates in women with advanced maternal age.
    Hagen A; Entezami M; Gasiorek-Wiens A; Albig M; Becker R; Knoll U; Stumm M; Wegner RD
    Ultraschall Med; 2011 Jun; 32(3):302-6. PubMed ID: 20972947
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Diagnostic accuracy of random massively parallel sequencing for non-invasive prenatal detection of common autosomal aneuploidies: a collaborative study in Europe.
    Stumm M; Entezami M; Haug K; Blank C; Wüstemann M; Schulze B; Raabe-Meyer G; Hempel M; Schelling M; Ostermayer E; Langer-Freitag S; Burkhardt T; Zimmermann R; Schleicher T; Weil B; Schöck U; Smerdka P; Grömminger S; Kumar Y; Hofmann W
    Prenat Diagn; 2014 Feb; 34(2):185-91. PubMed ID: 24222400
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Noninvasive prenatal screen of trisomy-21 using maternal plasma fetal free RNA allelic ratio].
    Xu Y; Zhai S; Luo X; Zhang Y; Ran L; Ren L
    Zhonghua Fu Chan Ke Za Zhi; 2015 Aug; 50(8):568-75. PubMed ID: 26675178
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis.
    Gil MM; Quezada MS; Revello R; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Mar; 45(3):249-66. PubMed ID: 25639627
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Analysis of the results of chromosomal trisomies 21, 18 and 13 screening among 40 628 women by non-invasive prenatal testing].
    Wang D; Yang J; Peng H; Hou Y; Wang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Nov; 38(11):1045-1050. PubMed ID: 34729740
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Screening for fetal aneuploidy.
    Rink BD; Norton ME
    Semin Perinatol; 2016 Feb; 40(1):35-43. PubMed ID: 26725144
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Prenatal diagnosis of women with an adverse reproductive history using both traditional karyotyping and SNP-array].
    Yu HS; Guo H; Shen SS; Li XC; Zhang LP; Fan XF
    Zhonghua Fu Chan Ke Za Zhi; 2018 Mar; 53(3):155-159. PubMed ID: 29609228
    [No Abstract]   [Full Text] [Related]  

  • 96. Committee Opinion No. 640: Cell-Free DNA Screening For Fetal Aneuploidy.
    Obstet Gynecol; 2015 Sep; 126(3):e31-e37. PubMed ID: 26287791
    [TBL] [Abstract][Full Text] [Related]  

  • 97. A prospective clinical trial to compare the performance of dried blood spots prenatal screening for Down's syndrome with conventional non-invasive testing technology.
    Hu H; Jiang Y; Zhang M; Liu S; Hao N; Zhou J; Liu J; Zhang X; Ma L
    Exp Biol Med (Maywood); 2017 Mar; 242(5):547-553. PubMed ID: 28056555
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies.
    Zhang H; Gao Y; Jiang F; Fu M; Yuan Y; Guo Y; Zhu Z; Lin M; Liu Q; Tian Z; Zhang H; Chen F; Lau TK; Zhao L; Yi X; Yin Y; Wang W
    Ultrasound Obstet Gynecol; 2015 May; 45(5):530-8. PubMed ID: 25598039
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Noninvasive prenatal testing for whole fetal chromosomal aneuploidies: a multicenter prospective cohort trial in Taiwan.
    Shaw SW; Hsiao CH; Chen CY; Ren Y; Tian F; Tsai C; Chen M; Cheng PJ
    Fetal Diagn Ther; 2014; 35(1):13-7. PubMed ID: 24296685
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [Prenatal diagnosis of heart defects and associated chromosomal aberrations].
    Chaoui R; Körner H; Bommer C; Göldner B; Bierlich A; Bollmann R
    Ultraschall Med; 1999 Oct; 20(5):177-84. PubMed ID: 10595385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 63.